Search Results - Charlie E Massie

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype

    DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype by Jyoti Nangalia, Francesca L. Nice, David C. Wedge, Anna L Godfrey, Jacob Grinfeld, Clare Thakker, Charlie E. Massie, Joanna Baxter, David Sewell, Yvonne Silber, Peter J. Campbell, Anthony R. Green

    Published 2015-11-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prostate cancer detection through unbiased capture of methylated cell-free DNA

    Prostate cancer detection through unbiased capture of methylated cell-free DNA by Ermira Lleshi, Toby Milne-Clark, Henson Lee Yu, Henno W. Martin, Robert Hanson, Radoslaw Lach, Sabrina H. Rossi, Anja Lisa Riediger, Magdalena Görtz, Holger Sültmann, Andrew Flewitt, Andy G. Lynch, Vincent J. Gnanapragasam, Charlie E. Massie, Harveer S. Dev

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates

    The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates by Claudia Buhigas, Anne Y. Warren, Wing-Kit Leung, Hayley C. Whitaker, Hayley J. Luxton, Steve Hawkins, Jonathan Kay, Adam Butler, Yaobo Xu, Dan J. Woodcock, Sue Merson, Fiona M. Frame, Atef Sahli, Federico Abascal, CRUK-ICGC Prostate Cancer Group, Iñigo Martincorena, G. Steven Bova, Christopher S. Foster, Peter Campbell, Norman J. Maitland, David E. Neal, Charlie E. Massie, Andy G. Lynch, Rosalind A. Eeles, Colin S. Cooper, David C. Wedge, Daniel S. Brewer

    Published 2022-09-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.

    Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. by Niedzica Camacho, Peter Van Loo, Sandra Edwards, Jonathan D Kay, Lucy Matthews, Kerstin Haase, Jeremy Clark, Nening Dennis, Sarah Thomas, Barbara Kremeyer, Jorge Zamora, Adam P Butler, Gunes Gundem, Sue Merson, Hayley Luxton, Steve Hawkins, Mohammed Ghori, Luke Marsden, Adam Lambert, Katalin Karaszi, Gill Pelvender, Charlie E Massie, Zsofia Kote-Jarai, Keiran Raine, David Jones, William J Howat, Steven Hazell, Naomi Livni, Cyril Fisher, Christopher Ogden, Pardeep Kumar, Alan Thompson, David Nicol, Erik Mayer, Tim Dudderidge, Yongwei Yu, Hongwei Zhang, Nimish C Shah, Vincent J Gnanapragasam, CRUK-ICGC Prostate Group, William Isaacs, Tapio Visakorpi, Freddie Hamdy, Dan Berney, Clare Verrill, Anne Y Warren, David C Wedge, Andrew G Lynch, Christopher S Foster, Yong Jie Lu, G Steven Bova, Hayley C Whitaker, Ultan McDermott, David E Neal, Rosalind Eeles, Rosalind Eeles, Colin S Cooper, Daniel S Brewer

    Published 2017-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: